What companies are DBVT's competitors?

DBV Technologies S.A. (DBVT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does DBVT compare to its peers?

The peer comparison table on this page shows DBV Technologies S.A. (DBVT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does DBVT operate in?

DBV Technologies S.A. (DBVT) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

DBVT

DBV Technologies S.A.

NASDAQ·Biotechnology · Healthcare

$9.98$0.23+2.36%

After hours·$9.98+0.00%

Market cap$238.74M·Market closed·Oct 26 4:00 PM EDT

Frequently Asked Questions About DBVT

What companies are DBVT's competitors?: DBV Technologies S.A. (DBVT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DBVT compare to its peers?: The peer comparison table on this page shows DBV Technologies S.A. (DBVT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DBVT operate in?: DBV Technologies S.A. (DBVT) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

DBVT

DBV Technologies S.A.

NASDAQ·Biotechnology · Healthcare

$9.98$0.23+2.36%

After hours·$9.98+0.00%

Market cap$238.74M·Market closed·Oct 26 4:00 PM EDT

Peers

Sort:


LBRXLBRXLB Pharmaceuticals Inc Common Stock	LB Pharmaceuticals Inc Common Stock	$39.34	$1.3B
ANROANROAlto Neuroscience, Inc.	Alto Neuroscience, Inc.	$22.11	$867.6M
ANNXANNXAnnexon, Inc.	Annexon, Inc.	$3.70	$606.2M
ALTALTAltimmune, Inc.	Altimmune, Inc.	$2.05	$398.8M
AMRNAMRNAmarin Corporation plc	Amarin Corporation plc	$12.09	$250.1M
LRMRLRMRLarimar Therapeutics, Inc.	Larimar Therapeutics, Inc.	$2.24	$232.7M
LXEOLXEOLexeo Therapeutics, Inc. Common Stock	Lexeo Therapeutics, Inc. Common Stock	$2.70	$221.6M
KRROKRROKorro Bio, Inc.	Korro Bio, Inc.	$12.02	$177.0M
ENGNENGNenGene Holdings Inc.	enGene Holdings Inc.	$1.58	$105.9M
CLLSCLLSCellectis S.A.	Cellectis S.A.	$0.97	$97.4M

Frequently Asked Questions About DBVT

What companies are DBVT's competitors?: DBV Technologies S.A. (DBVT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does DBVT compare to its peers?: The peer comparison table on this page shows DBV Technologies S.A. (DBVT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does DBVT operate in?: DBV Technologies S.A. (DBVT) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.